![Foto de Borja](/img/nophoto.png)
Borja
Barrera Cuesta
Publicaciones en las que colabora con Borja Barrera Cuesta (10)
2015
-
ABCG2/BCRP interaction with the sea grass Thalassia testudinum
Drug Metabolism and Personalized Therapy, Vol. 30, Núm. 4, pp. 251-256
-
Short communication: The gain-of-function Y581S polymorphism of the ABCG2 transporter increases secretion into milk of danofloxacin at the therapeutic dose for mastitis treatment
Journal of Dairy Science, Vol. 98, Núm. 1, pp. 312-317
2014
-
Structural determinants of peripheral O-arylcarbamate FAAH inhibitors render them dual substrates for Abcb1 and Abcg2 and restrict their access to the brain
Pharmacological Research, Vol. 87, pp. 87-93
2013
-
Effects of triclabendazole on secretion of danofloxacin and moxidectin into the milk of sheep: Role of triclabendazole metabolites as inhibitors of the ruminant ABCG2 transporter
Veterinary Journal, Vol. 198, Núm. 2, pp. 429-436
-
Inhibition of ABCG2/BCRP transporter by soy isoflavones genistein and daidzein: Effect on plasma and milk levels of danofloxacin in sheep
Veterinary Journal, Vol. 196, Núm. 2, pp. 203-208
2012
-
Reevaluation of the roles of ABCG2 in the disposition of genistein
Drug Metabolism and Disposition
-
The anthelmintic triclabendazole and its metabolites inhibit the membrane transporter ABCG2/BCRP
Antimicrobial Agents and Chemotherapy, Vol. 56, Núm. 7, pp. 3535-3543
2011
-
Bioavailability of the glucuronide and sulfate conjugates of genistein and daidzein in breast cancer resistance protein 1 knockout mice
Drug Metabolism and Disposition, Vol. 39, Núm. 11, pp. 2008-2012
-
Involvement of breast cancer resistance protein (BCRP/ABCG2) in the secretion of danofloxacin into milk: Interaction with ivermectin
Journal of Veterinary Pharmacology and Therapeutics, Vol. 34, Núm. 4, pp. 313-321
-
The ABC membrane transporter ABCG2 prevents access of FAAH inhibitor URB937 to the central nervous system
Pharmacological Research, Vol. 64, Núm. 4, pp. 359-363